152
Participants
Start Date
February 2, 2023
Primary Completion Date
June 19, 2025
Study Completion Date
May 28, 2028
Ianalumab
Concentrate for solution for infusion for intravenous use
Eltrombopag
Film-coated tablet for oral use
Placebo
Concentrate for solution for infusion for intravenous use.
Novartis Investigative Site, Quezon
Novartis Investigative Site, Makati City
Novartis Investigative Site, Debrecen
Novartis Investigative Site, Yvoir
Novartis Investigative Site, Ankara
Novartis Investigative Site, Roeselare
Novartis Investigative Site, George Town
Novartis Investigative Site, George Town
Montefiore Medical Center, The Bronx
Novartis Investigative Site, Bangkok
Hematology Oncology Association of Rockland, Nyack
Novartis Investigative Site, Santiago Compostela
Novartis Investigative Site, Saltillo
Novartis Investigative Site, Taoyuan District
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Trieste
Novartis Investigative Site, Izmir
Novartis Investigative Site, Salamanca
Novartis Investigative Site, Bologna
Novartis Investigative Site, Blois
Novartis Investigative Site, Subang Jaya
Michigan Center of Medical Research, Farmington Hills
Novartis Investigative Site, Chiang Mai
Novartis Investigative Site, Cologne
Novartis Investigative Site, Samsun
Novartis Investigative Site, Morelia
St Vincent Frontier Cancer Center, Billings
NorthShore University Health System, Evanston
Novartis Investigative Site, Monterrey
Novartis Investigative Site, Kuala Selangor
Novartis Investigative Site, Le Mans
Texas Oncology, Dallas
University of Colorado Anschutz, Aurora
Novartis Investigative Site, Johor Bahru
Community Cancer Trials of Utah, Ogden
Yuma Regional Medical Center, Yuma
Novartis Investigative Site, Kota Kinabalu
Novartis Investigative Site, Beijing
Novartis Investigative Site, Singapore
Novartis Investigative Site, Singapore
Novartis Investigative Site, Craiova
Novartis Investigative Site, Rishikesh
Novartis Investigative Site, Jinan
Novartis Investigative Site, Binzhou
Novartis Investigative Site, Tianjin
Novartis Investigative Site, Tianjin
Novartis Investigative Site, Timișoara
Novartis Investigative Site, Hangzhou
Novartis Investigative Site, Wuhan
Novartis Investigative Site, Guangzhou
Novartis Investigative Site, Jeollanam
Novartis Investigative Site, Kolkata
Boston Medical Center, Boston
UMASS Memorial Medical Center, Worcester
Novartis Investigative Site, CABA
Novartis Investigative Site, Vienna
Novartis Investigative Site, Brno
Novartis Investigative Site, Prague
Novartis Investigative Site, Prague
Novartis Investigative Site, Dresden
Novartis Investigative Site, Dresden
Novartis Investigative Site, Jena
Novartis Investigative Site, Budapest
Novartis Investigative Site, Roma
Novartis Investigative Site, Roma
Novartis Investigative Site, Nagoya
Novartis Investigative Site, Osaka
Novartis Investigative Site, Suita
Novartis Investigative Site, Kofu
Novartis Investigative Site, Kumamoto
Novartis Investigative Site, Leiden
Novartis Investigative Site, Utrecht
Novartis Investigative Site, Seoul
Novartis Investigative Site, Aydin
Novartis Investigative Site, London
Novartis Investigative Site, London
Novartis Investigative Site, Oxford
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY